CEOInterviews.AI
Start App
Andrew Huberman
Associate Professor of Neurobiology and Ophthalmology; Host, Huberman Lab, Stanford University

All Things Peptides — Dr. Andrew Huberman

📅 Jul 30, 2026 Tim Ferriss 11 MIN 113163 VIEWS 14 SEGMENTS · 2 SPEAKERS
Andrew Huberman, Ph.D., is a neuroscientist and tenured professor in the Departments of Neurobiology and Ophthalmology at Stanford University School of Medicine, where he runs the Huberman Lab. He is the author of Protocols: An Operating Manual for the Human Body: https://www.amazon.com/Protocols-Oper... This episode is brought to you by: ProLon science-backed Fasting Mimicking Diet that helps activate cellular renewal through fasting, while still eating nourishing meals: https://prolonlife.com/Tim Eight Sleep Pod Cover 5 sleeping solution for dynamic cooling and heating: https://www.eights...

What Andrew Huberman said

Written from the verified transcript and checked against it. Every figure links to the moment it was said.

Andrew Huberman discussed peptides, categorizing them into weight loss drugs like GLP agonists, growth hormone secretagogues, and BPC-157. He noted that GLP drugs raising levels thousandfold lead to robust weight loss but also muscle loss and potential apathy. He mentioned retatrutide, a Lilly drug hitting GLP, GIP, and glucagon systems, as most effective and muscle-sparing, though not yet formally released and available on the gray market. For growth hormone secretagogues like sermorelin, he shared personal experience of increased deep sleep but nuked REM and spiked PSA, leading him to stop. He suggested real GH at low doses as a better option. On BPC-157, he cited impressive animal data but no human trials, and recommended compounded pharmacy sourcing over gray market. He advised against ongoing use of BPC-157 unless injured.

Key takeaways

  1. Retatrutide, hitting GLP, GIP, and glucagon, is the most effective weight loss peptide and spares muscle, but is not yet formally released.
  2. GLP drugs that raise levels thousandfold cause robust weight loss but also muscle loss and potential apathy.
  3. Sermorelin increased Huberman's deep sleep but nuked REM and spiked PSA, which returned to normal after stopping.
  4. BPC-157 has impressive animal data but no published human trials; Huberman recommends compounded pharmacy sourcing over gray market.
  5. Huberman suggests low-dose GH (1-2 IUs nightly) as a better recovery option than unknown secretagogues.

Numbers and commitments

FigureWhat it refers toTypeAt
100-fold increase in GLP levels for diabetes treatment without much weight loss metric 2:35

Chapters

  1. 0:00Introduction to peptides
  2. 2:35GLP agonists and weight loss
  3. 8:30Sourcing and gray market risks

Questions asked in this interview

4
  1. 0:00What are these things? And what's your current thinking?
  2. 8:27How would you source that hypothetically?
  3. 9:48Like the challenge with so much of this stuff is you can't do the control, right?
  4. 10:36How did they get them in there?
Tim Ferriss 0:00 ↗
All right, Andrew, I want to ask you about peptides. All the rage. You look at Google Trends, everybody and their brother has a peptide startup, but there seems to maybe be something there. I don't know if there's a there there. For people who have heard the word, don't know exactly what folks are talking about. I get texted every week multiple times from people asking about various peptides. And I'd say half the time, depending on what they're trying to do, I'm like, can't you just be a grown-up and inject testosterone or HGH instead? If you're trying to get there directly. But I would be very interested to hear. I know there's a broad spectrum of stuff that people are experimenting with. What are these things? And what's your current thinking?
Andrew Huberman 0:43 ↗
I also don't completely disagree with you about like just be a grown-up and take cipionate and HGH. If you want to maintain fertility, take some HCG as well. And I'm being facetious, of course. I think there are risks to all of those, but it is the appropriate opening joke, because if you're expecting cipionate HGH type results from peptides, you ain't going to get them. At least not with respect to like anabolic growth, feelings of well-being. Peptides are short chains of amino acids. Insulin's a peptide, etc. I cannot take credit for what I'm about to say next, but it's a very, very important principle. I think this is kind of the theme today, I suppose. Abu Bakri, who's an MD, came on the podcast, talked about peptides, and he said, look, for many, many hundreds if not thousands of years, but certainly hundreds of years in the context of pharma, people have been searching for medicines in plants, isolating medicines from plants. Pharma companies still do this. Now people are starting to look for medicines within the body, and peptides are a great example of that. GLP, for instance, the drugs that increase GLP do so to thousandfold levels over the levels of circulating GLP that you would have, and they result in, as we all know, robust weight loss. So that's one category. I think we need to think about categories of peptides, but understand that peptides are all over. They're made in your brain and body. Some of them may have benefits when made synthetically and delivered at very, very high doses, such as with these GLP agonists, Ozempic, Mounjaro. Retatrutide is one that we should talk about, made by Lilly. It's coming out soon.
Tim Ferriss 2:27 ↗
It impacts the GLP system, but also the GIP and the glucagon system.
Andrew Huberman 2:31 ↗
Careful with that one, kiddos.
Tim Ferriss 2:32 ↗
A lot of people are going to be microdosing it.
Andrew Huberman 2:35 ↗
Yeah, a lot of people are finding that microdoses can have similar effects, and that's an important kind of cost-risk analysis. Okay, so stepping back, peptides are made in your body. They, at high concentrations made synthetically, they may provide benefits that make them medicines. So we can think of the weight loss peptides, the GLPs being the most prominent example. The GLP drugs that increased levels of GLP 100-fold were used to treat diabetes for a while, still are, but they didn't induce much weight loss. The ones that raise GLP levels thousandfold or more, those lead to robust weight loss, including muscle loss. And so that's part of the controversy. Also, there's discussion about maybe increasing some apathy. They reduce craving for alcohol and perhaps cravings more generally at the recommended dosages. In some people, they can create nausea, which is why some people are taking less of them and still getting the weight loss benefits, but less nausea. There's a lot of stuff going on there. To stay on the GLPs and weight loss peptides specifically, Lilly developed retatrutide, which hits the GLP, GIP, and glucagon system, leads to the most robust weight loss. Seems to spare some muscle. Perhaps people should always resistance train anyway to offset that. But it's the most effective of those weight loss, let's just call it GLPs, even though it hits these other systems. The gray market is the quote-unquote for research purposes only stuff that you can buy online. It's perfectly legal to sell for research purposes only, not for animal or human use. And I joked on X a while ago like, 'Wow, all these home labs, everyone's buying this. Of course, people are injecting them.' The concern is about contamination with things like lipopolysaccharide, or you're not getting what you think you're getting. So many people are already taking retatrutide even though it hasn't been formally released because it's pretty easy to synthesize. And so it's being sold on the gray market, people are taking it. There's a second category, and then I'll return to the kind of gray market issue. The second category would be things to increase growth hormone, so-called growth hormone secretagogues, things like sermorelin, ipamorelin, tesamorelin. These are all variants on the theme of get the brain neurons that project down to the pituitary to stimulate release of growth hormone at night. Typically, you don't eat a couple hours before sleep is the idea. Probably good for sleep anyway. It is good for sleep anyway. Then you inject this stuff. Typically, it leads to maybe a three- to eight-fold increase in growth hormone, IGF-1. Some stimulate appetite quite a bit, like MK-677. Some don't. I've tried sermorelin very briefly. Dramatically increased my slow-wave deep sleep. Nuked my REM sleep. This is a common theme. Spiked my prostate-specific antigen. I've never had any problems with PSA. I came off it. PSA went back to normal. No one's been able to give me a mechanistic explanation for that. I'm not about to run the experiment again. I didn't find that I got much fat loss from it, but I didn't use it very long. I didn't find I got stronger, you know, just didn't seem worth it to me given the PSA thing. A lot of people take these things and they're going to get these really dramatic increases in growth hormone. They sound dramatic, three- to eight-fold, but whether or not they're meaningful in terms of fat loss, it doesn't really seem they're that robust, especially given that you have all the GLPs now. So the growth hormone secretagogues also include things like CJC, and there are some variants on these which can lead to some insulin resistance but maybe spikes GH a bit more. I don't know. None of those to me really seem worth it personally, just given the effects aren't that great. You know, if someone can afford it and they can get a script for it, probably better to just take Genotropin or Omnitrope growth hormone. And you know, the bodybuilders would take like eight IUs a day or something crazy like that. But in the trials that have been done with metformin and GH, typically it's people are taking one to two IUs five nights per week. That will dramatically increase deep sleep and probably sleep overall, and the effects on fat loss and just tissue repair, healing, and feelings of well-being and just cognitive function. Anecdotally, people and subjectively people say like, 'Wow, I just feel so great.' This is the getting up in the morning and being like, 'Wow, my joints feel good,' and just being ready to like go, go, go. It's not anabolic as much as something like testosterone, etc. But I'm not telling people to run out and do GH. But if you could get a good script, a script for real GH and take a low dose versus taking a bunch of like unknown secret peptides, that seems like an obvious one for me. Then there's a category of things like BPC-157, body protection compound 157, which is an amino acid chain that is in gastric juice, but it's this isolated amino acid chain that seems to be the one that's most popular, and at the same time it's the one for which most people probably are taking it for all the wrong reasons. I've tried it. I definitely feel like after a pain or strain, the recovery is faster. But I can't do the control experiment because it goes systemic. So it's not like you could, let's say you hurt both biceps, you could, you can't inject into one bicep and not the other and assume that it's just acting locally. It's going to go systemically. There are capsule forms of BPC that people claim are just as good. I don't know. Do you have to inject locally close to the injury? It seems that might be helpful. The animal data on BPC are really impressive. Cartilage regrowth, fibroblast migration, angiogenesis, nerve regrowth. It's a literature I've spent a lot of time with. There's not a single published human trial. Where I think the most interesting use of it perhaps is, I know someone recently, she wrote to me and she said that her dog had a spinal injury, and she said, 'Does BPC work in animals?' I go, 'Actually, pretty much all the data are in animals.' So if my dog, god forbid, had an injury, I'd be willing to give him or her BPC. You have to work out the appropriate dosage.
Tim Ferriss 8:27 ↗
How would you source that hypothetically?

7 more exchanges in this transcript

Sign in free to read the rest of this interview. No card required.

Sign in to read the full transcript

Cite this transcript

APA, MLA, BibTeX
APA

Huberman, A. (2026, July 30). All Things Peptides — Dr. Andrew Huberman [Interview transcript]. Tim Ferriss. CEOInterviews.AI. https://ceointerviews.ai/interview/3006648/

MLA

Andrew Huberman. "All Things Peptides — Dr. Andrew Huberman." Tim Ferriss, 30 Jul. 2026. Transcript, CEOInterviews.AI, https://ceointerviews.ai/interview/3006648/.

BibTeX
@misc{huberman2026_3006648,
  author       = {Andrew Huberman},
  title        = {All Things Peptides — Dr. Andrew Huberman},
  howpublished = {Interview transcript, Tim Ferriss. CEOInterviews.AI},
  year         = {2026},
  month        = {jul},
  url          = {https://ceointerviews.ai/interview/3006648/},
  note         = {Speaker-attributed transcript with timestamps}
}